In‐hospital outcomes of transcatheter versus surgical mitral valve repair in patients with chronic liver disease

• DOI: 10.1111/ijcp.14660
• Publication Date: 2021-07-29T07:53:20Z
• Authors: Khalid Sawalha; Kamesh Gupta; Anis John Kadado; Mohammed Abozenah; Ayman Battisha; Colby Salerno; Ahmad Khan; Ashequl M. Islam
• Keywords: Liver disease

Background Mitral valve transcatheter edge-to-edge repair (TEER) using MitraClip is a treatment option for patients with moderate to severe mitral regurgitation who are not surgical candidate. Liver cirrhosis associated higher operative morbidity and mortality; however, it part of preoperative risk assessments calculators. We sought evaluate the in-hospital outcomes in TEER (SMVR) liver cirrhosis. Methods National Inpatient Database from 2013 2017 was used obtain all underwent or SMVR ICD-9-CM ICD-10-CM codes. The primary outcome compare inpatient mortality between SMVR. Secondary were assessed including length stay (LOS) rate complications cardiogenic shock, blood transfusion prolonged ventilation. Results A total 875 (n = 123) 752) identified our analysis. Patients had significantly comorbidities such as congestive heart failure, coronary artery disease chronic obstructive pulmonary disease. In-hospital lower group (8.2% vs 16%, P .04). rates (30.3% 61.2%, .02) reduced mechanical ventilation (1.2% 17.2%, .042). In multivariate regression analysis, both significant predictors Conclusions mortality, LOS, patients. can be considered viable patient regurgitation.